Dashboard
Manage Tickers

VTGNVistagen Therapeutics, Inc.

Nasdaq vistagen.com


$ 4.77 $ 0.06 (1.28 %)    

Friday, 19-Apr-2024 15:59:47 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 414.59 $ -8.76 (-2.07 %)
DIA $ 379.83 $ 1.96 (0.52 %)
SPY $ 494.96 $ -4.36 (-0.87 %)
TLT $ 89.15 $ 0.32 (0.36 %)
GLD $ 221.02 $ 0.69 (0.31 %)
$ 4.76
$ 4.66
$ 0.00 x 0
$ 0.00 x 0
$ 4.66 - $ 4.77
$ 1.62 - $ 24.71
152,105
na
37.47M
$ 1.18
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-13-2024 12-31-2023 10-Q
2 11-09-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 06-28-2023 03-31-2023 10-K
5 02-07-2023 12-31-2022 10-Q
6 11-10-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 06-23-2022 03-31-2022 10-K
9 02-10-2022 12-31-2021 10-Q
10 11-10-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 06-29-2021 03-31-2021 10-K
13 02-11-2021 12-31-2020 10-Q
14 11-12-2020 09-30-2020 10-Q
15 08-13-2020 06-30-2020 10-Q
16 06-30-2020 03-31-2020 10-K
17 02-13-2020 12-31-2019 10-Q
18 11-07-2019 09-30-2019 10-Q
19 08-13-2019 06-30-2019 10-Q
20 06-25-2019 03-31-2019 10-K
21 02-12-2019 12-31-2018 10-Q
22 10-29-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 06-26-2018 03-31-2018 10-K
25 02-12-2018 12-31-2017 10-Q
26 11-09-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 06-29-2017 03-31-2017 10-K
29 02-13-2017 12-31-2016 10-Q
30 11-14-2016 09-30-2016 10-Q
31 08-12-2016 06-30-2016 10-Q
32 06-24-2016 03-31-2016 10-K
33 02-16-2016 12-31-2015 10-Q
34 11-16-2015 09-30-2015 10-Q
35 08-14-2015 06-30-2015 10-Q
36 06-29-2015 03-31-2015 10-K
37 02-17-2015 12-31-2014 10-Q
38 11-19-2014 09-30-2014 10-Q
39 08-12-2014 06-30-2014 10-Q
40 06-25-2014 03-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

vistagen-initiates-palisade-3-phase-3-study-of-fasedienol-for-the-acute-treatment-of-social-anxiety-disorder-following-results-of-palisade-2
Vistagen Initiates PALISADE-3 Phase 3 Stud...
04/01/2024 12:31:37

Key study underway in registration-directed PALISADE Phase 3 program for fasedienol in social anxiety disorderSocial anxiety di...

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
02/19/2024 17:35:24

vistagen-therapeutics-q3-eps-022-beats-030-estimate-sales-41140k-miss-54450k-estimate
VistaGen Therapeutics Q3 EPS $(0.22) Beats...
02/13/2024 21:31:01

VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of...

recap-vistagen-therapeutics-q3-earnings
Recap: Vistagen Therapeutics Q3 Earnings
02/13/2024 21:25:07

earnings-scheduled-for-february-13-2024
Earnings Scheduled For February 13, 2024
02/13/2024 10:05:59

Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on reven...

vistagen-therapeuticss-earnings-a-preview
VistaGen Therapeutics's Earnings: A Preview
02/12/2024 19:01:36

vistagen-receives-notice-from-european-patent-office-of-intention-to-grant-patent-for-av-101-to-treat-neuropathic-pain
Vistagen Receives Notice From European Pat...
12/27/2023 13:30:48

Preclinical data in four well-established preclinical models of pain associated with tissue inflammation and nerve injury demon...

jefferies-upgrades-vistagen-therapeutics-to-buy-raises-price-target-to-15
Jefferies Upgrades Vistagen Therapeutics t...
12/07/2023 10:35:02

Jefferies analyst Andrew Tsai upgrades Vistagen Therapeutics (NASDAQ:VTGN) from Hold to Buy and raises the price target from...

hearing-vistagen-therapeutics-upgraded-from-a-hold-to-a-buy-at-jefferies-price-target-15
Hearing Vistagen Therapeutics Upgraded Fro...
12/07/2023 00:10:59

undervalued-vistagen-therapeutics-analyst-highlights-potential-in-anxiety-treatment
Undervalued VistaGen Therapeutics, Analyst...
12/04/2023 19:39:15

William Blair initiated coverage on VistaGen Therapeutics Inc (NASDAQ: VTGN), a clinical-stage biopharmaceutical company focuse...

anxiety-focused-stock-vistagen-therapeutics-is-an-undervalued-late-stage-neurology-player-analyst
Anxiety-Focused Stock Vistagen Therapeutic...
11/14/2023 19:08:02

Analysts at Stifel recently initiated coverage on Vistagen Therapeutics Inc (NASDAQ: VTGN), emphasizing the potential of its le...

stifel-initiates-coverage-on-vistagen-therapeutics-with-buy-rating-announces-price-target-of-12
Stifel Initiates Coverage On Vistagen Ther...
11/14/2023 17:47:38

Stifel analyst Paul Matteis initiates coverage on Vistagen Therapeutics (NASDAQ:VTGN) with a Buy rating and announces Price ...

vistagen-therapeutics-q2-2024-eps-066-beats-068-estimate-sales-27770k-beat-18000k-estimate
VistaGen Therapeutics Q2 2024 EPS $(0.66) ...
11/09/2023 21:49:21

VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of...

earnings-scheduled-for-november-9-2023
Earnings Scheduled For November 9, 2023
11/09/2023 11:52:51

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

vistagen-therapeutics-earnings-preview
VistaGen Therapeutics Earnings Preview
11/08/2023 19:01:35

vistagen-to-present-fasedienol-phase-3-data-and-ph80-phase-2a-data-at-upcoming-scientific-conferences
Vistagen To Present Fasedienol Phase 3 Dat...
11/07/2023 13:35:17

Positive top-line results from fasedienol (PH94B) Phase 3 PALISADE-2 trial in social anxiety disorder (SAD) to be presented by ...

why-vistagen-therapeutics-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket
Why Vistagen Therapeutics Shares Are Tradi...
10/17/2023 12:12:51

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares surged 79.5% to $5.08 in pre-market trading after falling around 7% on Monday. ...

vistagen-therapeutics-13g-filing-shows-citadel-advisors-llc-reports-56-stake-in-co
VistaGen Therapeutics 13G Filing Shows Cit...
10/16/2023 20:05:03

- SEC Filing

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
10/05/2023 21:32:13

point72-asset-management-lp-holds-56-passive-stake-in-vistagen-therapeutics---13g-filing
Point72 Asset Management, L.P. Holds 5.6% ...
10/05/2023 20:52:27

https://www.sec.gov/Archives/edgar/data/1411685/000090266423005016/p23-2550sc13g.htm

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

04/22/2024 Dick's Sporting Goods, Inc. (DKS)
04/22/2024 Innodata Inc. (INOD)
04/22/2024 Fox Factory Holding Corp. (FOXF)
04/23/2024 Lantronix, Inc. (LTRX)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)